Welcome to our dedicated page for Calvert US Select Equity ETF news (Ticker: CVSE), a resource for investors and traders seeking the latest updates and insights on Calvert US Select Equity ETF stock.
Calvert US Select Equity ETF (CVSE) is an exchange-traded fund that is a series of Morgan Stanley ETF Trust. News related to CVSE is centered on the Fund’s approved Plan of Liquidation, as announced by Morgan Stanley Investment Management, Inc. This plan provides for the liquidation of the Fund’s assets, the satisfaction or provision for its known or reasonably ascertainable liabilities, and the distribution of remaining proceeds to shareholders, followed by the redemption of all outstanding shares.
Coverage about CVSE focuses on the timeline and mechanics of this wind-down process. The announcement explains that the Fund is expected to have a last full day of trading on NYSE Arca, Inc., after which trading in its shares is anticipated to be halted. News items may highlight that shareholders can sell their shares on NYSE Arca up to that final trading day or remain invested to receive a liquidating distribution on the liquidation date. They may also describe how authorized participants can continue to submit redemption orders for Creation Units as set out in the Fund’s prospectus.
Another area of attention in CVSE-related news is the impact of the liquidation on the Fund’s investment objective and management. The Fund is described as transitioning its holdings into cash and cash equivalents as part of winding up its business and affairs. During this period, it may no longer follow its previously stated investment strategies, which is noted as likely to affect performance. Articles may also reference the tax implications noted in the announcement, where the sale or liquidation of shares is generally treated as a taxable event unless held in certain tax-deferred accounts.
Investors and observers who follow CVSE news can use these updates to understand the Fund’s trading status on NYSE Arca, the expected treatment of shareholder interests during the wind-down, and the structural changes associated with the Plan of Liquidation.
Morgan Stanley Investment Management has announced the liquidation of the Calvert US Select Equity ETF (CVSE), scheduled for October 20, 2025. The Fund will cease accepting Creation Unit orders and stop trading on NYSE Arca after market close on October 14, 2025.
Shareholders have two options: sell their shares on NYSE Arca until October 14, 2025, or remain invested until the Liquidation Date to receive a liquidating distribution. During the wind-down period, the Fund will transition its assets to cash and cash equivalents, which may impact its performance and investment objectives.
Investors should note that the liquidation will be considered a taxable event for shares not held in tax-deferred accounts, and remaining shareholders may face increased brokerage and transaction expenses.
FAQ
What is the current stock price of Calvert US Select Equity ETF (CVSE)?
